Antifungals Flashcards
Nearly __% of deaths due to nosocomial infections are due to fungi
_______ is responsile for 70%
40%; Candida
Predisposition to Serious Fungal Infections
Immunocompromised
- Chemotherapy
- Immunomodulation
- Organ transplantation
- AIDS
Broad spectrum antibacterials use
Indwelling catheters
Difficulties in Treating Fungal Infections
- Fungi are Eukaryotes
- Number of agents available for clinical use is small
- Many fungal infections occur in poorly vascularized areas
Classification of Mycoses
- Systemic
- Debilitated or immunosuppressed patients
- Geographically localized
- Occupational
- Superficial
- Mucous membranes
- Dermatophytic
Potential Antifungal Targets
- Membranes (ergosterol)
- Nucleic acids (limited)
- Cell wall (1 drug class)
Drugs used for systemic fungal infections
- Amphotericin B
- Flucytosine
- Imidazoles
- Fluconazole
- Itraconazole
- Voriconazole
- Caspofungin
Amphotericin B
- Effective for:
- Effective (broad spectrum agent) for most serious systemic mycoses
- Especially those that are immediately life threatening
- Gold standard for anti fungal effectiveness by which other drugs are judged
Amphotericin B is _______ at serum levels in humans
Fungistatic
Mechanism of Action: Amphotericin
Forms a pore in the fungal membrane - causes leaky membranes
Amphotericin B
Administration and Dosing:
- Prolonged therapy usually necessary (6-12 weeks)
- Administration
- IV
- Intrathecally or intraperitoneally
- Not absorbed from GI tract
- Total cumulative dose is also important for reasonse of permanent renal toxicity
- Difficult to administer - highly lipophilic; amphotericin deoxycholate suspension (3 lipid forms now available)
Amphotericin - Side Effects
Ampho-Terrible
- Fever, nausea, vomiting, headache, chills
- Hypotension, hypokalemia, tachypnea
- 90% will show nonpermanent nephrotoxicity
- Permanent renal damage can occur
- Reversible hypochromic, normocytic anemia
Flucystosine (5-FC)
Uses:
- Serious infections
- Candida, Cryptococcus
- Used in conjunction with amphotericin B
- Fungistatic
5-FC Mechanism of Action
- Crosses fungal wall with cytosine permease
- Fungal cytosine deaminase (5-FC →5-FU)
- Inside the fungus
- Inhibits thymidylate synthtease and thus DNA synthesis
- Incorporated in RNA in place of Uracil
Flucytosine - Side Effects
- Nausea, vomiting, diarrhea, enterocolitis
- Leukopenia, thrombocytopenia
- Reversible elevated hepatic enzymes
- Use extreme caution in those with renal insufficiency or bone marrow depression
Other drugs for serious fungal infections (relative to amphotericin)
- Narrower spectrum of action
- Some not for immediately life-threatening infections
- Have fewer/less serious side effects
Imadazole and Triazole antifungals for serious fungal infections
- Fluconazole
- Voriconazole
- Itraconazole
Mechanism of action of imidazoles and triazoles
- Inhibits 14-α-sterol demethylase, a fungal cytochrome P450 that converts lanosterol to ergosterol
- Net effect is to inhibit ergosterol synthesis, which eventually leads to membrane instability
Fluonazole
Fungi and clinical use:
- Cryptococcus: meningitis
- Candida: many sites including CNS and urinary
- Candida spectrum
- Some albicans and glabrata
- Not C. crusei
Itraconazole
Fungi and clinical use:
- Blastomyces, Histoplasma
- Candida: Esophagus and oropharynx (not CNS and urinary)
- Candida spectrum
- More albicans and glabrata
- Some C. krusei in vitro
Voriconazole
Fungi and clinical use:
- Aspergillus
- Fusarium
- Scedosporium
- Cadida
- Covers many species including glabrata and krusei